Blefari F, Risi O, Pino P
Divisione Urologia, Ospedale Consorziale, Treviglio e Caravaggio (Bergamo) USSL BG/32, Regione Lombardia.
Minerva Urol Nefrol. 1991 Oct-Dec;43(4):293-5.
The therapeutical effectiveness of beta-interferon and the possibility of reducing the incidence of relapses were evaluated by submitting two groups of 10 patients each to various treatment. The first group has been treated only by electro-fulguration and the second also by parenteral administration of beta-interferon. We obtained 60% of relapse (good result in 4 cases) in the first group and 20% (good result in 8 cases) in the second group. No side effects have been reported by patients treated by interferon. We conclude that systemic beta-interferon can be active in treating patients with condylomata acuminata in association with electro-fulguration.
通过对两组各10名患者进行不同治疗，评估了β-干扰素的治疗效果以及降低复发率的可能性。第一组仅接受电灼治疗，第二组除电灼治疗外还接受β-干扰素的肠胃外给药。第一组的复发率为60%（4例效果良好），第二组为20%（8例效果良好）。接受干扰素治疗的患者未报告有副作用。我们得出结论，全身性β-干扰素与电灼联合应用时可有效治疗尖锐湿疣患者。
